CORT FY 2024 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$675M+39.9% YoY

Gross Profit

$664M98.4% margin

Operating Income

$137M20.3% margin

Net Income

$140M20.7% margin

EPS (Diluted)

$1.23

Cash Flow

Operating Cash Flow

$198M

Free Cash Flow

$196M

Stock-Based Comp.

$61M

Balance Sheet

Total Assets

$841M

Total Liabilities

$161M

Stockholders' Equity

$680M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$675M	$482M	+39.9%
Gross Profit	$664M	$476M	+39.6%
Operating Income	$137M	$107M	+27.7%
Net Income	$140M	$106M	+31.6%